Amy Eichner is explaining what you need to know about GLP-1s and how these drugs may impact your young athlete
Excessive weight gain and central obesity (usually begins after age 2 years) Higher pain threshold Substantially slow metabolic rate Hypothalamic hypogonadism Scoliosis and/or kyphosis Sleep-disordered breathing, central sleep apnea (under age 2 years), obstructive sleep apnea, hypoventilation, excessive daytime sleepiness, narcolepsy, cataplexy Small hands and feet Articulation challenges, Apraxia of Speech, hypernasal speech, language processing challenges Thick viscous saliva Absent vomit reflex or elevated vomiting threshold Temperature regulation irregularities Temperament, emotional regulation, and behavioral challenges beginning after age 2 years Clinical Symptoms in Older Children and Adults without intervention: Symptoms in the young children and: Hyperphagia: insatiable drive to eat or find food to eat later, lack of normal satiety
Non-peptide is a chemical description
As with other areas of womens health, when women get older, changes in the body affect their ability to absorb B12 adequately
Protocols should be approved by institutional review board before starting the study
For diagnosed insulin resistance with clinical indication for medication , metformin is the prescription standard, and berberine at 1,500 milligrams daily has shown comparable metabolic effects in head-to-head comparison (Wei et al